Modafinil and Protein total abnormal - a phase IV clinical study of FDA data
Protein total abnormal is reported only by a few people who take Modafinil.
The phase IV clinical study analyzes which people take Modafinil and have Protein total abnormal. It is created by eHealthMe based on reports of 16,746 people who have side effects while taking Modafinil from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
16,746 people reported to have side effects when taking Modafinil.
Among them, 2 people (0.01%) have Protein total abnormal.
What is Modafinil?
Modafinil has active ingredients of modafinil. It is often used in narcolepsy. eHealthMe is studying from 17,529 Modafinil users for its effectiveness, alternative drugs and more.
What is Protein total abnormal?
Protein total abnormal is found to be associated with 442 drugs and 218 conditions by eHealthMe.
Number of Modafinil and Protein total abnormal reports submitted per year:
Gender of people who have Protein total abnormal when taking Modafinil *:
- female: 100 %
- male: 0.0 %
Age of people who have Protein total abnormal when taking Modafinil *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 0.0 %
- 60+: 100 %
Common drugs people take besides Modafinil *:
- Nystop: 2 people, 100.00%
- Metoclopramide Hcl: 2 people, 100.00%
- Linzess: 2 people, 100.00%
- Hydrocodone: 2 people, 100.00%
- Aubagio: 2 people, 100.00%
- Amlodipine: 2 people, 100.00%
- Adderall: 2 people, 100.00%
* Approximation only. Some reports may have incomplete information.
Do you take Modafinil and have Protein total abnormal?Check whether Protein total abnormal is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Lopes E, Pereira D, da Silva Behrens NS, de Almeida Fonseca H, Calvancanti PO, de Araújo Lima TF, Pradella-Hallinan M, Castro J, Tufik S, Coelho FM, "Cataplexy as a side effect of modafinil in a patient without narcolepsy", Sleep Science, 2014 Mar .
How severe was Protein total abnormal and when was it recovered:
Expand to all the drugs that have ingredients of modafinil:
Alternative drugs to, pros and cons of Modafinil:
- Modafinil (17,529 reports)
Common Modafinil side effects:
Browse all side effects of Modafinil:a b c d e f g h i j k l m n o p q r s t u v w x y z
Protein total abnormal treatments and more:
- Protein total abnormal (1,549 reports)
COVID vaccines that are related to Protein total abnormal:
- Protein total abnormal in Moderna COVID Vaccine
- Protein total abnormal in Pfizer BioNTech Covid Vaccine
- Protein total abnormal in Johnson and Johnson Covid Vaccine
All the drugs that are associated with Protein total abnormal:
- Protein total abnormal (442 drugs)
All the conditions that are associated with Protein total abnormal:
- Protein total abnormal (218 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on modafinil (the active ingredients of Modafinil) and Modafinil (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Isoniazid and Dysphemia - a second ago
- Lumify and Breathing Difficulty - 5 seconds ago
- Vaginal Bleeding in Aspirin, how severe and when it was recovered? - 16 seconds ago
- Trusopt and Omeprazole drug interaction - 23 seconds ago
- Flexeril vs. Chondroitin And Glucosamine - 42 seconds ago
- Paracetamol and Acute Cerebellar Ataxia - 47 seconds ago
- Testosterone Enanthate and Appetite - Decreased - 48 seconds ago
- Testosterone Enanthate and Appetite Decreased - 48 seconds ago
- Tramadol Hydrochloride and Atrovent Hfa drug interaction - a minute ago
- Pradaxa and Hepatitis Fulminant - a minute ago